A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis

Qianfoshan Hospital

Status: Enrolling

Conditions: Interstitial Lung Disease

Study type: Observational

Funder types: Other

Identifiers

NCT05895409

YXLL-KY-2023(029)

Details and patient eligibility

About

The goal of this observational study is to learn about risk of progressive pulmonary fibrosis (PPF). The main questions it aims to answer are:

• Risk factors of PPF
• Prevalence of PPF
• Mortality of PPF

Patients with interstitial lung disease (ILD) of known or unknown etiology other than IPF who has radiological evidence of pulmonary fibrosis will enroll in this study.

• All participants will have baseline investigations at the first visit having provided informed consent.
• At the first visit, baseline characteristics will be collected including demographics, medical history, smoking history, complications and medication use. 50 mL of blood will be obtained. High resolution computed tomography (HRCT), full lung function tests and a 6 min walk test will be performed.
• Further visits at 6 months and 12 months will include further 50 mL blood sampling. HRCT, full lung function tests and a 6 min walk test will be repeated.

Enrollment: 610 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18-80 years old
• Agree and sign the informed consent form
• Interstitial lung disease patients with imaging features of pulmonary fibrosis

Exclusion criteria

• Patients with idiopathic pulmonary fibrosis (IPF)
• Pregnant or lactating women
• mental illness or cognitive impairment
• participating in other clinical studies
• Unable to sign informed consent form

Trial design

610 participants in 1 patient group

PF

Description:

Patients with interstitial lung disease (ILD) of known or unknown etiology other than IPF who has radiological evidence of pulmonary fibrosis(PF).